🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Canada / NCT05659485
Recruiting Observational

Measuring Family Engagement in Care (The FAME Study)

NCT05659485 · tracked via the Priya Life Science Canada tracker
Phase
Observational
Started
2023-01-31
Last updated
2025-02-13

Condition(s) studied

Family EngagementPatient-centered CareCritical Care

Study summary

There are currently no validated tools to specifically measure family engagement in the intensive care unit (ICU). To address this gap, an interdisciplinary team developed a novel instrument to measure family engagement in the ICU. This will be a prospective observational cohort with an embedded qualitative study to validate the FAMily Engagement (FAME) instrument in the ICU setting. This study will also evaluate the association between family activation, engagement, and family-centred outcomes, and exploring factors (age, relationship, sex, gender, race/ethnicity) that may influence family engagement in the ICU.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Family member of patient admitted to the intensive care units * Able to participate in English or French * Age 18 years old or older Exclusion Criteria: * ICU stays less than 24 hours * Another family member has already participated in the study

Primary outcome measure(s)

Trial sites (6)

FacilityCityRegionStatus
Foothills Medical Centre Calgary Alberta Active Not Recruiting
St. Michael's Hospital Toronto Ontario Suspended
Jewish General Hospital / Lady Davis Institute Montreal Quebec Recruiting
Centre hospitalier de l'Université de Montréal (CHUM) Montreal Quebec Active Not Recruiting
Montreal General Hospital Montreal Quebec Recruiting
Royal Victoria Hospital Montreal Quebec Recruiting

More Lady Davis Institute trials in Canada

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05659485 on ClinicalTrials.gov ↗ ← All trials in Canada